Clinical implications of p57 KIP2 expression in breast cancer

• Published in: Asian Pacific journal of cancer prevention : APJCP Vol. 13; no. 10; p. 5033
• Main Authors: Xu, Xiao-Yin, Wang, Wen-Qian, Zhang, Lei, Li, Yi-Ming, Tang, Miao, Jiang, Nan, Cai, Shou-Liang, Wei, Liang, Jin, Feng, Chen, Bo
• Format: Journal Article
• Language: English
• Published: Thailand 2012
• Subjects: Adult; Aged; Aged, 80 and over; Breast - metabolism; Breast - pathology; Breast Neoplasms - drug therapy; Breast Neoplasms - metabolism; Breast Neoplasms - mortality; Carcinoma, Ductal, Breast - drug therapy; Carcinoma, Ductal, Breast - metabolism; Carcinoma, Ductal, Breast - mortality; Case-Control Studies; Cyclin-Dependent Kinase Inhibitor p57 - metabolism; Female; Follow-Up Studies; Humans; Immunoenzyme Techniques; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Prognosis; Receptor, ErbB-2 - metabolism; Survival Rate

To study the relationship between expression of p57KIP2 and prognosis and other clinicopathological parameters in invasive breast cancers. We assessed the expression of p57KIP2 in 89 cases of invasive breast cancer and 20 cases of normal breast tissue by immunohistochemical methods and analyzed the...